Patents Assigned to Medigenbio Corporation
  • Patent number: 8524976
    Abstract: The present invention relates to a ?-L-iduronidase knock-out mouse. More particularly, this invention relates to a ?-L-iduronidase knock-out mouse to be designed for developing a treatment or an agent for mucopolysaccharidosis type I (Hurler syndrome or Hurler-Scheie syndrome) as an animal model.
    Type: Grant
    Filed: September 17, 2009
    Date of Patent: September 3, 2013
    Assignee: Medigenbio Corporation
    Inventor: Thong-Gyu Jin